{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:29:09Z","timestamp":1791959349108,"version":"4.3.4"},"reference-count":50,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2016,12,16]],"date-time":"2016-12-16T00:00:00Z","timestamp":1481846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Coccidioidomycosis (Valley Fever) is a disease caused by inhalation of Coccidioides spp. This neglected disease has substantial public health impact despite its geographic restriction to desert areas of the southwestern U.S., Mexico, Central and South America. The incidence of this infection in California and Arizona has been increasing over the past fifteen years. Several large cities are within the endemic region in the U.S. Coccidioidomycosis accounts for 25,000 hospital admissions per year in California. While most cases of coccidioidomycosis resolve spontaneously, up to 40% are severe enough to require anti-fungal treatment, and a significant number disseminate beyond the lungs. Disseminated infection involving the meninges is fatal without appropriate treatment. Infection with Coccidioides spp. is protective against a second infection, so vaccination seems biologically plausible. This review of efforts to develop a vaccine against coccidioidomycosis focuses on vaccine approaches and the difficulties in identifying protein antigen\/adjuvant combinations that protect in experimental mouse models. Although the quest for a vaccine is still in the early stage, scientific efforts for vaccine development may pave the way for future success.<\/jats:p>","DOI":"10.3390\/jof2040034","type":"journal-article","created":{"date-parts":[[2016,12,16]],"date-time":"2016-12-16T10:55:28Z","timestamp":1481885728000},"page":"34","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The Quest for a Vaccine Against Coccidioidomycosis: A Neglected Disease of the Americas"],"prefix":"10.3390","volume":"2","author":[{"given":"Theo","family":"Kirkland","sequence":"first","affiliation":[{"name":"Departments of Pathology and Medicine, University of California, San Diego, School of Medicine, San Diego, CA 92161, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,12,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1073\/pnas.071406098","article-title":"Biogeographic range expansion into South America by Coccidioides immitis mirrors new world patterns of human migration","volume":"98","author":"Fisher","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/mmy\/myt005","article-title":"Genetic analysis of the endemic fungal pathogens Coccidioides posadasii and Coccidioides immitis in Mexico","volume":"52","author":"Gonzalez","year":"2014","journal-title":"Med. Mycol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/CMR.00005-13","article-title":"Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of Coccidioidomycosis","volume":"26","author":"Nguyen","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1001\/jama.1997.03540350054033","article-title":"A Coccidioidomycosis outbreak following the Northridge, Calif, Earthquake","volume":"277","author":"Schneider","year":"1997","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1086\/496991","article-title":"Coccidioidomycosis","volume":"41","author":"Galgiani","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","unstructured":"CDC (2013). Increase in reported Coccidioidomycosis\u2014United States, 1998\u20132011. MMWR, 62, 1\u201320."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid1910.130427","article-title":"Coccidioidomycosis-associated hospitalizations, California, USA, 2000\u20132011","volume":"19","author":"Sondermeyer","year":"2013","journal-title":"Emerg. Infect. Dis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3201\/eid1206.060028","article-title":"Coccidioidomycosis as a common cause of community-acquired pneumonia","volume":"12","author":"Valdivia","year":"2006","journal-title":"Emerg. Infect. Dis"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Thompson, G., Brown, J., Benedict, K., and Park, B. (2013). Coccidioidomycosis: Epidemiology. CLEP, 185\u2013197.","DOI":"10.2147\/CLEP.S34434"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1128\/CMR.17.4.804-839.2004","article-title":"Coccidioidomycosis: Host response and vaccine development","volume":"17","author":"Cox","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3201\/eid0203.960305","article-title":"Coccidioidomycosis: a Reemerging infectious disease","volume":"2","author":"Kirkland","year":"1996","journal-title":"Emerg. Infect. Dis"},{"key":"ref_12","first-page":"0015","article-title":"Coccidioidomycosis\u2014A fungal disease of the Americas","volume":"2","author":"Hector","year":"2005","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.3201\/eid1611.100475","article-title":"Enhanced surveillance of Coccidioidomycosis, Arizona, USA, 2007\u20132008","volume":"16","author":"Tsang","year":"2010","journal-title":"Emerg. Infect. Dis"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4612-3730-3_6","article-title":"Epidemiology of Coccidioidomycosis","volume":"2","author":"Pappagianis","year":"1988","journal-title":"Curr. Top. Med. Mycol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/0003-4819-124-3-199602010-00004","article-title":"Is It Ever Safe to Stop Azole Therapy for Coccidioides Immitis meningitis?","volume":"124","author":"Dewsnup","year":"1996","journal-title":"Ann. Intern. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1534\/g3.115.022806","article-title":"Comparative phylogenomics of pathogenic and nonpathogenic species","volume":"6","author":"Whiston","year":"2016","journal-title":"G3"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Viriyakosol, S., Singhania, A., Fierer, J., Goldberg, J., Kirkland, T.N., and Woelk, C.H. (2013). Gene expression in human fungal pathogen Coccidioides Immitis changes as arthroconidia differentiate into spherules and mature. BMC Microbiol., 13.","DOI":"10.1186\/1471-2180-13-121"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Whiston, E., Zhang Wise, H., Sharpton, T.J., Jui, G., Cole, G.T., and Taylor, J.W. (2012). Comparative transcriptomics of the saprobic and parasitic growth phases in Coccidioides spp.. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0041034"},{"key":"ref_19","first-page":"330","article-title":"The use of Coccidioidin","volume":"57","author":"Smith","year":"1948","journal-title":"Am. Rev. Tuberc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jama.1956.02960420026008","article-title":"Pattern of 39,500 serologic tests in Coccidioidomycosis","volume":"160","author":"Smith","year":"1956","journal-title":"J. Am. Med. Assoc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1128\/JCM.43.11.5462-5469.2005","article-title":"Characterization of a serodiagnostic complement fixation antigen of Coccidioides posadasii expressed in the nonpathogenic fungus Uncinocarpus reesii","volume":"43","author":"Yu","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_22","first-page":"1039","article-title":"In vitro whole-blood analysis of cellular immunity in patients with active Coccidioidomycosis by using the antigen preparation T27K","volume":"9","author":"Ampel","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/infdis\/jit246","article-title":"Immunological characterization of bronchoalveolar lavage fluid in patients with acute pulmonary Coccidioidomycosis","volume":"208","author":"Nesbit","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1172\/JCI43984","article-title":"Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice","volume":"121","author":"Gern","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Margolis, D.A., Viriyakosol, S., Fierer, J., and Kirkland, T.N. (2011). The Role of reactive oxygen intermediates in experimental Coccidioidomycois in mice. BMC Microbiol., 11.","DOI":"10.1186\/1471-2180-11-71"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.micpath.2011.03.013","article-title":"Nitric oxide synthase activity has limited influence on the control of Coccidioides infection in mice","volume":"51","author":"Gonzalez","year":"2011","journal-title":"Microb. Pathog."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1128\/iai.40.3.912-916.1983","article-title":"Inbred mouse strains differ in resistance to lethal Coccidioides Immitis infection","volume":"40","author":"Kirkland","year":"1983","journal-title":"Infect. Immun."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/br.31.1.35-53.1967","article-title":"Experimentally induced immunity in the mycoses","volume":"31","author":"Kong","year":"1967","journal-title":"Bacteriol. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1128\/IAI.66.5.2342-2345.1998","article-title":"Protection against lethal murine Coccidioidomycosis by a soluble vaccine from spherules","volume":"66","author":"Zimmermann","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1128\/IAI.00459-09","article-title":"A Genetically engineered live attenuated vaccine of Coccidioides Posadasii protects BALB\/C mice against Coccidioidomycosis","volume":"77","author":"Xue","year":"2009","journal-title":"Infect. Immun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1128\/IAI.00633-16","article-title":"A Coccidioides CPS1 deletion mutant is avirulent and protects mice from lethal infection","volume":"84","author":"Narra","year":"2016","journal-title":"Infect. Immun."},{"key":"ref_32","first-page":"656","article-title":"Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans","volume":"148","author":"Pappagianis","year":"1993","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1128\/IAI.67.6.2935-2940.1999","article-title":"Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigen","volume":"67","author":"Abuodeh","year":"1999","journal-title":"Infect. Immun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1128\/IAI.71.6.3010-3019.2003","article-title":"A Recombinant \u03b2-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against Coccidioidomycosis","volume":"71","author":"Delgado","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.chom.2015.02.009","article-title":"Calnexin induces expansion of antigen-specific CD4+ T cells that confer immunity to fungal ascomycetes via conserved epitopes","volume":"17","author":"Brandhorst","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1128\/IAI.74.1.516-527.2006","article-title":"A Recombinant aspartyl protease of coccidioides Posadasii induces protection against pulmonary Coccidioidomycosis in mice","volume":"74","author":"Tarcha","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1016\/j.vaccine.2006.04.002","article-title":"Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein","volume":"24","author":"Shubitz","year":"2006","journal-title":"Vaccine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1128\/IAI.00566-12","article-title":"Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis","volume":"80","author":"Hurtgen","year":"2012","journal-title":"Infect. Immun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1101\/gr.087551.108","article-title":"Comparative genomic analyses of the human fungal pathogens Coccidioides and their relatives","volume":"19","author":"Sharpton","year":"2009","journal-title":"Genome Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/IAI.68.2.584-593.2000","article-title":"A Major cell surface antigen of Coccidioides immitis which elicits both humoral and cellular immune responses","volume":"68","author":"Hung","year":"2000","journal-title":"Infect. Immun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/iai.20.2.541-551.1978","article-title":"Antigenic analysis of coccidioidin and spherulin determined by two-dimensional immunoelectrophoresis","volume":"20","author":"Huppert","year":"1978","journal-title":"Infect. Immun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1128\/iai.64.7.2695-2699.1996","article-title":"Molecular cloning and characterization of Coccidioides immitis antigen 2 cDNA","volume":"64","author":"Zhu","year":"1996","journal-title":"Infect. Immun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1006\/bbrc.1996.0086","article-title":"Cloning and sequence analysis of the cDNA for a protein from Coccidioides immitis with immunogenic potential","volume":"218","author":"Dugger","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.vaccine.2005.07.092","article-title":"Molecular and cellular mechanisms of protective immunity to Coccidioidomycosis","volume":"24","author":"Kirkland","year":"2006","journal-title":"Vaccine"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/molbev\/msh124","article-title":"Positive directional selection in the proline-rich antigen (PRA) gene among the human pathogenic fungi Coccidioides immitis, C. posadasii and their closest relatives","volume":"21","author":"Johannesson","year":"2004","journal-title":"Mol. Biol. Evol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1128\/IAI.00961-06","article-title":"Multivalent recombinant protein vaccine against Coccidioidomycosis","volume":"74","author":"Tarcha","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1128\/IAI.74.3.1865-1872.2006","article-title":"Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate","volume":"74","author":"Orsborn","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1038\/cti.2016.22","article-title":"Toll-Like Receptors: The Swiss army knife of immunity and vaccine development","volume":"5","author":"Dowling","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1196\/annals.1406.042","article-title":"Safety, antigenicity, and efficacy of a recombinant Coccidioidomycosis vaccine in Cynomolgus Macaques (Macaca Fascicularis)","volume":"1111","author":"Johnson","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1196\/annals.1406.007","article-title":"Comparative aspects of Coccidioidomycosis in animals and human","volume":"1111","author":"Shubitz","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/2\/4\/34\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:28:45Z","timestamp":1760210925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/2\/4\/34"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,16]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,12]]}},"alternative-id":["jof2040034"],"URL":"https:\/\/doi.org\/10.3390\/jof2040034","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints201612.0076.v1","asserted-by":"object"}]},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,16]]}}}